Status:
UNKNOWN
Final Height in Patients With CH Diagnosed by the Screening
Lead Sponsor:
Ain Shams University
Conditions:
Congenital Hypothyroidism
Eligibility:
All Genders
Brief Summary
The aim of this study is to evaluate longitudinal growth and final height in patients with Congenital Hypothyroidism detected by neonatal screening and factors affecting it.
Detailed Description
Linear growth and final height are reported as rather normal in patients with CH diagnosed through the screening and the target height is the most important factor determining linear growth. Data on f...
Eligibility Criteria
Inclusion
- Patients having a documented history of CH diagnosed by Egyptian neonatal screening program.
- Patients receiving L-thyroxine (L-T4) since the diagnosis is established.
Exclusion
- Patients who are non-compliant on L-thyroxine (L-T4) and failed to follow up at the clinic on regular basis.
- Patients who were missed from diagnosis by neonatal screening.
- Patients with associated hormonal disorders affecting same parameters concerned in the study.
Key Trial Info
Start Date :
November 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04734457
Start Date
November 2 2021
End Date
April 1 2022
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abbasiya, Egypt, 1181